Stay updated with breaking news from Cell Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ginkgo added 13 new Cell Programs to the Foundry platform in Q1 2023 Recent acquisition of the adeno-associated virus capsid engineering platform assets of StrideBio is advancing Ginkgo's... | May 10, 2023
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today...
Expects to meet 2022 guidance ranges for Total revenue and new Cell Programs Year end cash balance of approximately $1.3 billion provides ample liquidity and...
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), the leading horizontal platform for cell programming, today announced its results for...
$145 million of Total revenue in Q2 2022, representing 231% growth over Q2 202113 new Cell Programs added in Q2 2022, representing 86% growth over...